The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

ConditionInfluenza
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-99
SponsorUniversity of Colorado, Denver

About this trial

This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.

Eligibility criteria

Qualifiers

At least 6 months of age

Admitted to an inpatient unit at a participating health system

Disqualifiers

At least 6 months of age

Admitted to an inpatient unit at a participating health system

Trial design

Treatments tested in this trial

  • Existing Influenza Vaccination Practices
  • Standardized inpatient influenza vaccination program

Treatment groups

22,000 Participants
are divided into 2 treatment groups

Locations

2
Ann and Robert Lurie's Children Hospital of Chicago60611, ChicagoIllinois, United States
Seattle Children's Hospital98105, SeattleWashington, United States

Sponsors and collaborators

University of Colorado, Denver

Lead sponsor

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Seattle Children's Hospital

Collaborator